Treatment of endometriosis with gonadotropin releasing hormone agonist (buserelin).

Sirimongkolkasem, R; Rojanasakul, A; Chailurkit, L O

Sirimongkolkasem, R; Rojanasakul, A; Chailurkit, L O.

Artículo en Inglés | IMSEAR | ID: sea-42964

ABSTRACT

ABSTRACT

The results of treatment of endometriosis with intranasal buserelin is convincing. The drug effectively suppresses serum estradiol to the menopausal level. Clinical improvement and regression of endometriotic lesions were observed during treatment. Thus, buserelin offers an alternative medical treatment of endometriosis. Further studies of the effects of GnRH agonist on bone mass are needed.

Asunto(s)

Adulto; Buserelina/uso terapéutico; Endometriosis/sangre; Estradiol/sangre; Femenino; Gonadotropinas Hipofisarias/sangre; Humanos; Progesterona/sangre; Neoplasias Uterinas/sangre

Texto completo

Imprimir

XML

Buscar en Google

Texto completo: Disponible Índice: IMSEAR (Asia Sudoriental) Asunto principal: Progesterona / Neoplasias Uterinas / Femenino / Humanos / Buserelina / Adulto / Endometriosis / Estradiol / Gonadotropinas Hipofisarias Idioma: Inglés Año: 1990 Tipo del documento: Artículo

Similares

MEDLINE

LILACS

LIS

Texto completo

Imprimir

XML

Buscar en Google